Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO4917523 adjunctive therapy in major depressive disorder with inadequate antidepressant response
2011-001436-33Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of basimglurant in major depressive disorder (MDD) (3 arms), sponsored by Roche. Started Sep 2011; status: completed.
02
Drugs
basimglurant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2011-001436-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001436-33.